These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4050889)

  • 1. Hyperthyroidism in end-stage renal disease.
    Foley RJ; Hamner RW
    Am J Nephrol; 1985; 5(4):292-5. PubMed ID: 4050889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical hyperthyroidism in a patient receiving long-term hemodialysis.
    Soffer O; Chary KR; Hall WD
    Arch Intern Med; 1980 May; 140(5):708-9. PubMed ID: 7396599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic anxiety disorder secondary to hyperthyroidism in a hemodialysis patient. A rare occurrence.
    Alarcon RD; Groover AM; Jenkins-Ross CS
    Psychosomatics; 1992; 33(4):457-60. PubMed ID: 1461973
    [No Abstract]   [Full Text] [Related]  

  • 4. Iodine-131 treatment of hyperthyroidism in a patient on dialysis for chronic renal failure.
    Nibhanupudy JR; Hamilton W; Sridhar R; Talley GB; Chughtai GM; Ashayeri E; Goldson AL
    Am J Nephrol; 1993; 13(3):214-7. PubMed ID: 8213934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of atrial fibrillation and factors related to its development in dialysis patients.
    Atar I; Konaş D; Açikel S; Külah E; Atar A; Bozbaş H; Gülmez O; Sezer S; Yildirir A; Ozdemir N; Müderrisoğlu H; Ozin B
    Int J Cardiol; 2006 Jan; 106(1):47-51. PubMed ID: 16321665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of hyperthyroidism with radioactive iodine in end-stage renal disease patients undergoing dialysis].
    Niemczyk S; Matuszkiewicz-Rowińska J; Stopiński M; Grochowski J; Sitkowska-Kurzec Z; Przedlacki J; Chojnowski K; Królicki L
    Pol Arch Med Wewn; 2004 Aug; 112(2):931-6. PubMed ID: 15675268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of Graves' disease during regular hemodialysis.
    Maruyama S; Ikarashi T; Soda S; Toya M; Okamura K; Hirayama S; Suzuki K; Hanyu O; Sakurabayashi T; Nakagawa O; Aizawa Y
    Clin Exp Nephrol; 2004 Mar; 8(1):71-4. PubMed ID: 15067521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation.
    Wongcharoen W; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Chong E; Chao TF; Tuan TC; Chang YT; Lin CY; Liao JN; Lin YC; Chen YY; Chen SA
    Heart Rhythm; 2015 Sep; 12(9):1956-62. PubMed ID: 26049050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthyroidism in haemodialysis patients: report on a case and review of the literature.
    Koutsikos D; Fourtounas C; Kapetanaki A; Tzanatos H; Agroyannis B; Kopelias I; Bovoleti O; Bosiolis B
    Nephrol Dial Transplant; 1995; 10(9):1765-7. PubMed ID: 8559504
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperthyroidism and the management of atrial fibrillation.
    Shimizu T; Koide S; Noh JY; Sugino K; Ito K; Nakazawa H
    Thyroid; 2002 Jun; 12(6):489-93. PubMed ID: 12165111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of thyroid dysfunction on erythropoietin dosage in hemodialysis patients.
    Ng YY; Lin HD; Wu SC; Yang CY; Yang WC; Liou HH; Hu FH; Hou CC; Tseng SS; Ku NY; Hsiao NY; Wu WC; Tu HM; Lien TJ; Lee CC; Tsang KK; Cheng CS; Hu J; Lin RP
    Thyroid; 2013 May; 23(5):552-61. PubMed ID: 23189968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The reversibility of pulmonary hypertension associated with autoimmune hyperthyroidism].
    Alcázar R; Rey M; de Sequera P; Alegre R; Rovira A; Caramelo C
    Rev Esp Cardiol; 1995 Feb; 48(2):142-4. PubMed ID: 7886265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation associated with subclinical hyperthyroidism.
    Patanè S; Marte F
    Int J Cardiol; 2009 May; 134(3):e155-8. PubMed ID: 19185365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity?].
    Toft P; Bøtker HE
    Ugeskr Laeger; 1993 May; 155(18):1354-7. PubMed ID: 8497965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbimazole therapy in the setting of end-stage renal disease and haemodialysis.
    Varughese GI; Tahrani AA; Smith JL; Clayton RN; Hanna FW
    Nephrol Dial Transplant; 2006 Aug; 21(8):2318-9. PubMed ID: 16702200
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac risks of hyperthyroidism in the elderly.
    Kahaly GJ; Nieswandt J; Mohr-Kahaly S
    Thyroid; 1998 Dec; 8(12):1165-9. PubMed ID: 9920373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxysmal ventricular tachycardia and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate-specific antigen during acute myocardial infarction.
    Patanè S; Marte F
    Int J Cardiol; 2010 Feb; 138(3):e44-6. PubMed ID: 18722027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic multinodular goiter in a patient with end-stage renal disease and hemodialysis.
    So E; Arakaki R
    Hawaii J Med Public Health; 2014 Jul; 73(7):217-20. PubMed ID: 25089233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis.
    Holst JP; Burman KD; Atkins F; Umans JG; Jonklaas J
    Thyroid; 2005 Dec; 15(12):1321-31. PubMed ID: 16405403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperthyroidism and hemodialysis].
    Martín Hernández T; Torres Cuadro A; Gijón Trigueros A; Lorenzo Carrero J
    An Med Interna; 1995 Aug; 12(8):391-2. PubMed ID: 8924530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.